Skip to main content
SpringerLink
Log in

Maligne Lymphome

  • Zum Thema
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Coiffier B, Lepage E, Briere J et al.(2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell-lymphoma. N Engl J Med 346:235–242

    Article  CAS  PubMed  Google Scholar 

  2. Glass B, Kloess M, Berdel W et al.(2002) Mega- CHOEP: a phase I/II study of the German High Grade NHL Study Group for primary treatment of aggressive non-Hodgkin’s lymphoma: efficacy of dose level 1+2 and feasibility of dose level 3 (abstract). Bone Marrow Transplant 29 [Suppl 2]: No.O111

    Google Scholar 

  3. Harris NL, Jaffe ES, Diebold J, Müller-Hermelink HK, Vardiman J, Lister TA, Bloomfiled CD (1999) The World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues. J Clin Oncol 17:3835–3849

    CAS  PubMed  Google Scholar 

  4. Harris NL, Stein H, Coupland SE, Hummel M, Dalla Favera R, Pasqualucci L, Chan WC (2001) New approaches to lymphoma diagnosis. Hematology (ASH Education Program Book), pp 194–220

    Google Scholar 

  5. Hiddemann W, Pfreundschuh M, Diehl V et al. (2001) Myeloablative radiochemotherapy with autologous stem cell transplantation in indolent lymphoma — results of a prospective randomised comparison of the German Low Grade Lymphoma Study Group (abstract). Onkologie 24 [Suppl 6]: No. 357

    Google Scholar 

  6. Hiddemann W, Forstpointner R, Fiedler F et al. (2001) The addition of rituximab to combination chemotherapy with fludarabine, cyclophosphamide, mitoxantrone (FCM) results in a significant increase of overall response as compared to FCM alone in patients with relapsed or refractory follicular (FCL) and mantel cell lymphoma (MCL) — results of a prospective randomised comparison of the German Low Grade Lymphoma Study Group (GLSG) (abstract). Blood 98 [Suppl 1]: No.3507

    Google Scholar 

  7. Hiddemann W, Dreyling M, Unterhalt M (2001) Aktuelle Entwicklungen in der Therapie follikulärer Keimzentrumslymphome. Onkologe 7:969–981

    Article  Google Scholar 

  8. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 329:987–949

    Article  Google Scholar 

  9. Miller TP, Dahlberg S, Cassady JR et al. (1998) Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin’s lymphoma. New Engl J Med 339:21–26

    Article  CAS  PubMed  Google Scholar 

  10. Pfreundschuh M, Trümper L, Kloess M et al. (2001) CHOEP (CHOP + Etoposide): the new standard regimen for younger patients with low risk (low LDH) aggressive non-Hodgkin’s lymphoma (abstract). Blood 98 [Suppl 1]: No.3026

    Google Scholar 

  11. Pfreundschuh M, Trümper L, Kloess M et al. (2001) 2-weekly CHOP (CHOP-14): the new standard regimen for patients with aggressive non-Hodgkin’s lymphoma (NHL) >60 years of age (abstract). Blood 98 [Suppl 1]: No.3027

    Google Scholar 

  12. Rübe C, Nguyen TP, Klöss M, Loeffler M, Trümper L, Pfreundschuh M (2001) Consolidation radiotherapy to bulky disease in aggressive NHL.First results of the NHL B-94 trial of the DSHNHL. Ann Hematol 80 [Suppl III]: B84–B85

    PubMed  Google Scholar 

  13. Rübe C, Nguyen TP, Brinkmann R (2002) The value of radiation therapy in the management of aggressive non-Hodgkin’s lymphomas. Onkologie 25: 214–220

    Article  PubMed  Google Scholar 

  14. Schmits R, Hartmann F, Beelen D, Pfreundschuh M (2001) Neue Standards in der Therapie aggressiver Lymphome. Onkologe 7:998–1013

    Article  Google Scholar 

  15. Shenkier TN, Voss N, Fairey R et al. (2002) Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency. J Clin Oncol 20:197–204

    Article  CAS  PubMed  Google Scholar 

  16. Tiemann M, Trümper L (2001) Pathologie, Biologie und Klassifikation maligner Non-Hodgkin-Lymphome. Onkologe 7:940–959

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik I, Universitätskliniken des Saarlandes, Kirrberger Straße, 66421, Homburg, Deutschland

    Frank Hartmann

Authors
  1. Frank Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frank Hartmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hartmann, F. Maligne Lymphome. Onkologe 8 (Suppl 1), s21–s27 (2002). https://doi.org/10.1007/s00761-002-0374-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-002-0374-0

Search

Navigation